Skip Nav Destination
A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412
Clin Cancer Res (2022) 28 (23): 5088–5097.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Juan C. Fierro Pineda
- Mary Frances Wedekind
- John W. Glod
Current Opinion in Pediatrics (2023) 35 (1): 63.